Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Holly Williams

REVEALED: Gsk sees falling vaccine sales take shine off earnings - The Real Truth

Drugs giant GSK has seen shares come under pressure as falling vaccine sales overshadowed a better-than-forecast rise in quarterly profits (PA) - (PA Archive)

Drugs giant GSK has seen shares come under pressure as falling vaccine sales overshadowed a better-than-forecast rise in quarterly profits.

The British pharmaceutical firm revealed vaccine sales fell 2% to £2.6 billion in the three months to September 30 as demand waned for its shingles jab Shingrix and Arexvy shot for the respiratory virus RSV.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.